2010Journal of Pain ResearchOpen access

Extended-release morphine sulfate in treatment of severe acute and chronic pain

Andrea Trescot

Open full text 25 citations

Abstract

Abstract: Morphine is the archetypal opioid analgesic. Because it is a short-acting opioid, its use has been limited to the management of acute pain. The development of extended-release formulations have resulted in the increased utilization of morphine in chronic pain conditions. This review documents the history of morphine use in pain treatment, and describes the metabolism, pharmacodynamics, formulations, and efficacy of the currently available extended-release morphine medications. Keywords: Morphine ER, sustained-release morphine, MSContin, Oramorph ® , Kadian ® , Avinza ® , Embeda ®

Open-access reader

About this research paper

What this paper is about

Abstract: Morphine is the archetypal opioid analgesic. Because it is a short-acting opioid, its use has been limited to the management of acute pain. The development of extended-release formulations have resulted in the increased utilization of morphine in chronic pain conditions. This review documents the history of morphine use in pain treatment, and describes the metabolism, pharmacodynamics, formulations, and efficacy of the currently available extended-release morphine medications. Keywords: Morphine ER, sustained-release morphine, MSContin, Oramorph ® , Kadian ® , Avinza ® , Embeda ®

Why it matters

OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract: Morphine is the archetypal opioid analgesic. Because it is a short-acting opioid, its use has been limited to the management of acute pain. The development of extended-release formulations have resulted in the increased utilization of morphine in chronic pain conditions. This review documents the history of morphine use in pain treatment, and describes the metabolism, pharmacodynamics, formulations, and efficacy of the currently available extended-release morphine medications. Keywords: Morphine ER, sustained-release morphine, MSContin, Oramorph ® , Kadian ® , Avinza ® , Embeda ®

Key concepts: Medicine, Morphine sulfate, Morphine, Chronic pain, Acute pain, Anesthesia, Intensive care medicine, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Extended-release morphine sulfate in treatment of severe acute and chronic pain — Research Paper | ScholarLens